drug

SNV1521

1 story · latest Aug 10, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Synnovation Therapeutics, INC

Timeline

Synnovation registers Phase 1 trial of SNV1521 with Revolution Medicines' daraxonrasib

Aug 10Trial updatedaraxonrasib Revolution Medicines, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.